Michael Baumann, Ph.D.
Dr. Michael Baumann is Director of the Designer Drug Research Unit, the goal of which is to collect, analyze, and disseminate current information about the pharmacology and toxicology of emerging synthetic drugs of abuse. His current research is aimed at determining the biological effects of emerging synthetic stimulants, cannabinoids, and opioids that pose serious public health risks. Dr. Baumann received his Ph.D. in physiology and neurobiology from Rutgers University.
About This Talk
Designer drugs are also known as new psychoactive substances (NPS). All NPS are designed to bypass drug control laws, so the drugs are legal when first appearing in recreational drug markets. There are NPS representing most major classes of psychoactive drugs, including stimulants, cannabinoids, and opioids. Dr. Baumann will discuss the molecular mechanism of action, behavioral effects, and adverse consequences of each drug class.
Audiences: high school, college, community